To include your compound in the COVID-19 Resource Center, submit it here.
Hyperion acquired worldwide rights to Ravicti glycerol phenylbutyrate ( HPN-100) from Medicis' Ucyclyd Pharma Inc. subsidiary. The
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury